为什么英国要为老年人群接种 RSV 疫苗--老年病学专家应该知道的事

IF 6 2区医学 Q1 GERIATRICS & GERONTOLOGY

Age and ageing Pub Date : 2024-09-24 DOI:10.1093/ageing/afae202

Johnny Naylor, Antonia Ho, Roy L Soiza

{"title":"为什么英国要为老年人群接种 RSV 疫苗--老年病学专家应该知道的事","authors":"Johnny Naylor, Antonia Ho, Roy L Soiza","doi":"10.1093/ageing/afae202","DOIUrl":null,"url":null,"abstract":"The UK is launching a new free vaccination programme against respiratory syncytial virus (RSV) in adults aged 75 or over. This follows the development of safe and effective vaccines against RSV and the growing realisation of the burden of RSV-related disease in older adults—estimated at circa 8000 deaths and 175 000 GP episodes every year in the UK. It is likely that the full burden of RSV-related illness is under-appreciated and under-reported due to a lack of testing and awareness of its dangers in older adults. Healthcare professionals working with older people should be aware of the evidence base and be in a position to advise patients on the risks and benefits of vaccination and nonvaccination. We briefly review the evidence for the safety and effectiveness of the two licensed vaccines against RSV with a special focus on what geriatricians and others working with frailer, older people need to know.","PeriodicalId":7682,"journal":{"name":"Age and ageing","volume":"62 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Why the UK is vaccinating its older adult population against RSV—what geriatricians should know\",\"authors\":\"Johnny Naylor, Antonia Ho, Roy L Soiza\",\"doi\":\"10.1093/ageing/afae202\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The UK is launching a new free vaccination programme against respiratory syncytial virus (RSV) in adults aged 75 or over. This follows the development of safe and effective vaccines against RSV and the growing realisation of the burden of RSV-related disease in older adults—estimated at circa 8000 deaths and 175 000 GP episodes every year in the UK. It is likely that the full burden of RSV-related illness is under-appreciated and under-reported due to a lack of testing and awareness of its dangers in older adults. Healthcare professionals working with older people should be aware of the evidence base and be in a position to advise patients on the risks and benefits of vaccination and nonvaccination. We briefly review the evidence for the safety and effectiveness of the two licensed vaccines against RSV with a special focus on what geriatricians and others working with frailer, older people need to know.\",\"PeriodicalId\":7682,\"journal\":{\"name\":\"Age and ageing\",\"volume\":\"62 1\",\"pages\":\"\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2024-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Age and ageing\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ageing/afae202\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Age and ageing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ageing/afae202","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

英国正在为 75 岁或以上的成年人启动一项新的免费呼吸道合胞病毒 (RSV) 疫苗接种计划。在此之前，英国已开发出安全有效的 RSV 疫苗，而且人们日益认识到老年人与 RSV 相关疾病的负担--据估计，英国每年约有 8000 人死亡，175000 人次在全科医生处就诊。由于缺乏对老年人 RSV 危险的检测和认识，与 RSV 相关疾病的全部负担很可能未得到充分重视和报告。为老年人提供服务的医疗保健专业人员应该了解证据基础，并能够就接种和不接种疫苗的风险和益处向患者提供建议。我们简要回顾了两种获得许可的 RSV 疫苗的安全性和有效性证据，并特别强调了老年病学家和其他从事体弱老年人工作的人员需要了解的内容。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Why the UK is vaccinating its older adult population against RSV—what geriatricians should know

The UK is launching a new free vaccination programme against respiratory syncytial virus (RSV) in adults aged 75 or over. This follows the development of safe and effective vaccines against RSV and the growing realisation of the burden of RSV-related disease in older adults—estimated at circa 8000 deaths and 175 000 GP episodes every year in the UK. It is likely that the full burden of RSV-related illness is under-appreciated and under-reported due to a lack of testing and awareness of its dangers in older adults. Healthcare professionals working with older people should be aware of the evidence base and be in a position to advise patients on the risks and benefits of vaccination and nonvaccination. We briefly review the evidence for the safety and effectiveness of the two licensed vaccines against RSV with a special focus on what geriatricians and others working with frailer, older people need to know.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Age and ageing 医学-老年医学

CiteScore

9.20

自引率

6.00%

发文量

796

审稿时长

4-8 weeks

期刊介绍： Age and Ageing is an international journal publishing refereed original articles and commissioned reviews on geriatric medicine and gerontology. Its range includes research on ageing and clinical, epidemiological, and psychological aspects of later life.